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Summary 
 
 The inheritance of functional mitochondria depends on faithful replication and 
transmission of mitochondrial DNA (mtDNA). A large and heterogeneous group of human 
disorders is associated with mitochondrial genome quantitative and qualitative anomalies. 
Several nuclear genes have been shown to account for these severe OXPHOS disorders. 
However, in several cases the disease-causing mutations still remain unknown. 
 C. elegans has been largely used for studying various biological functions as this 
multicellular organism has short life cycle and is easy to grow in the laboratory. Mitochondrial 
functions are relatively well conserved between human and C. elegans and heteroplasmy 
exists in this organism as in human. C. elegans therefore represent a useful tool for studying 
mtDNA maintenance. Suppression by RNA interference of genes involved in mtDNA 
replication such as polg-1, encoding the mitochondrial DNA polymerase, results in reduced 
mtDNA copy number but in a normal phenotype of the F1 worms. By combining RNAi of 
genes involved in mtDNA maintenance and EtBr exposure we were able to reveal a strong 
and specific phenotype (developmental larval arrest) associated to a severe decrease of 
mtDNA copy number. Moreover, we tested and validated the screen efficiency for human 
orthologous genes encoding mitochondrial nucleoid proteins. This allowed us to identify 
several genes that seem to be closely related to mtDNA maintenance in C. elegans. 
 This work reports a first step in the further development of a large-scale screening in 
C. elegans that should allow to identify new genes of mtDNA maintenance whose human 
orthologs will obviously constitute new candidate genes for patients with quantitative or 
qualitative mtDNA anomalies. 
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Introduction 
Mitochondria play an essential role in cellular energy production provided by the 
mitochondrial respiratory chain. The inheritance of functional mitochondria depends on 
faithful replication and transmission of mitochondrial DNA (mtDNA). The mitochondrial 
genome encodes only a few proteins of the respiratory chain (RC) complexes whereas all 
other mitochondrial proteins are encoded in the nucleus, synthesized on cytosolic ribosomes 
and imported into mitochondria. The mitochondrially encoded proteins are essential for the 
proper function of the respiratory chain and expression of those subunits requires that the 
mitochondrial genome be replicated, transcribed and translated. The newly synthesized 
subunits are subsequently assembled with nuclear encoded subunits. Over the past years, 
while key details of the content and expression of the mitochondrial genome have been 
elucidated, important questions remain regarding the maintenance and the transmission of 
mtDNA during cell proliferation and development. 
A large and heterogeneous group of disorders is associated with mitochondrial 
genome anomalies in human. Mutations in nuclear genes encoding proteins involved in 
mtDNA maintenance can result in large-scale mtDNA rearrangements (mtDNA deletion) and 
abnormal copy number (mtDNA depletion) of the mitochondrial genome. Autosomal 
dominant progressive external ophthalmoplegia (adPEO) is an adult-onset mitochondrial 
disorder characterized by ophthalmoparesis with exercise intolerance, ataxia, peripheral 
neuropathy, and multiple mtDNA deletions [1, 2]. Familial ad-PEO is genetically 
heterogeneous, and at least six nuclear genes account for this disease, namely, ANT1, 
encoding the adenosine diphosphate-triphosphate translocator [3, 4], POLG1 [5] and 
POLG2 [6] encoding the catalytic and accessory subunits of the mtDNA polymerase, PEO1 
encoding the Twinkle DNA helicase [1], OPA1 encoding a mitochondrial dynamin-related 
GTPase [7] and RRM2B encoding the p53-inducible small subunit of ribonucleotide 
reductase [8]. 
mtDNA depletion syndrome (MDS) is a clinically and genetically heterogeneous group 
of autosomal recessive diseases characterized by a reduction in mtDNA copy number [9]. 
Several nuclear genes have been shown to account for these severe OXPHOS disorders. 
Indeed, mutations in the deoxyguanosine kinase (DGUOK) and the thymidine kinase genes 
(TK2) have been reported in the hepatocerebral and myopathic forms of MDS [10, 11] 
respectively. Also, POLG1 mutations associated with Alpers’ syndrome [12, 13] as well as 
the hepatocerebral form lead to mtDNA depletion. Mutations in TP gene encoding the 
cytosolic thymidine phosphorylase result in mitochondrial neurogastrointestinal 
encephalopathy (MNGIE) syndrome with mtDNA deletion and depletion [14]. The succinyl 
coenzyme A-ligase subunits (SUCLA2, [15] and SUCLG1 [16]) and MPV17 [17] genes have 
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also been shown to account for mtDNA depletion in a few pedigrees. Finally, mutations of 
RRM2B encoding a small subunit of the cytosolic ribonucleotide reductase have been 
reported to cause severe muscle mtDNA depletion [18]. All these genes are involved in 
mtDNA maintenance or dNTP metabolism. However, in several cases of ad-PEO and MDS 
the disease-causing mutations remain still unknown. 
The suitability of the yeast Saccharomyces cerevisiae as a model for human 
mitochondrial studies has been well demonstrated. However notable differences in mtDNA 
structure and dynamics between yeast and human did not make it a perfect tool to study the 
mtDNA maintenance. Indeed, human cells contain102–104 mtDNA copies whereas yeast 
cells contain only 20–100 copies. The mitochondrial genome, 16.6 kb in human and 85.8 kb 
in yeast, is predominantly linear in yeast but is circular in human [19-21]. Finally 
heteroplasmy is very frequently observed for mtDNA mutations in human whereas yeast 
cannot normally maintain stably heteroplasmy [22, 23]. Furthermore, because this yeast can 
grow robustly by fermentation in the absence of mtDNA, it loses its mitochondrial genome 
very rapidly upon inactivation of a large class of genes encoding mitochondrial proteins 
involved in almost all the mitochondrial biogenesis pathways (mitochondrial translation, ATP 
synthesis, iron homeostasis, mitochondrial import and morphology). As such it cannot be 
used easily to address the question of mtDNA transmission control [24].  
The characteristics of Caenorhabditis elegans make it a perfect complement to the 
yeast system. While C. elegans has been largely used for studying various biological 
functions such as neuron development or apoptosis, few studies have focused on 
mitochondria. Its mitochondrial genome (13.7 kb) has been fully sequenced, it encodes 12 
mitochondrial RC subunits and is similar in size and gene content to its human counterpart 
[25]. The group of B. Lemire has brought a large contribution by showing that heteroplasmy 
exists in this organism as in human as far as mtDNA deletions are considered [26]. This 
team also showed that mtDNA copy number is coordinated with the maturation steps of C. 
elegans life cycle. Indeed, mtDNA amplification is necessary for normal development as 
blocking mtDNA replication results in development arrest [27]. The mtDNA copy number is 
strictly regulated during C. elegans development. Indeed, mtDNA content that is maternally 
derived remains essentially unchanged from embryo up to the L3 larval stage. The copy 
number then increases at least 3-fold in L4 larvae and is associated with somatic cells 
development and gonad formation. A further huge increase in mtDNA content takes place in 
adult hermaphrodites during oogenesis and high production of embryo [27, 28]. Finally, 
blockage of mtDNA replication by ethidium bromide (EtBr), a well-known molecule acting as 
a DNA-intercaling dye and potent inhibitor of mtDNA transcription and replication [29-31] 
results in developmental arrest [27]. Surprisingly, inactivation by RNA interference (RNAi) 
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over one generation of genes encoding proteins essential for mtDNA replication such as 
polg-1 (DNA polymerase γ) or mtss-1 (mitochondrial single-stranded DNA-binding protein) 
does not give rise to a strong phenotype [32-36]. Only continuous exposure to RNAi over 
several generations revealed an abnormal phenotype (gonad protrusion and sterility, [37]). 
Furthermore, homozygous polg-1 knockout mutants had normal development rates indicating 
a high maternal contribution of polg-1. However, loss of polg-1 leads to complete sterility and 
shortened lifespan. Moreover during adult life, worms failed to maintain normal mtDNA levels 
[28].  
Several genes are known to be involved in mtDNA maintenance in various species. 
Not only genes encoding mitochondrial proteins but also cytosolic proteins are involved in 
this mechanism such as RRM2B and TP in human. This suggests that unexpected genes 
could be required for normal mtDNA metabolism that have to be identified. In the present 
study, we designed an efficient and rapid screening for the identification of genes required for 
mtDNA maintenance in the worm C. elegans by combining RNAi and EtBr exposure. 
Considering that mitochondrial functions are relatively well conserved during evolution, the 
systematic use of this screen for all C. elegans genes will certainly allow to identify new 
genes of mtDNA maintenance whose human orthologs could obviously constitute new 
candidate genes for patients.  
 
Results 
polg-1 and mtss-1 knock down results in mtDNA depletion  
 We first silenced two genes, polg-1 and mtss-1 in wild-type animals. These two genes 
are orthologs to the human POLG1 and SSBP1 genes encoding the mitochondrial DNA 
polymerase γ and the single strand DNA binding protein respectively, both genes being 
involved in mtDNA replication. Synchronized N2 embryos were subjected to RNAi feeding 
until the adult stage and during the F1 progeny. As expected, the F1 progeny developed into 
adulthood with no strong phenotype (Fig. 1A). We next estimated by quantitative PCR the 
mtDNA copy number in F1 adults having laid all their eggs to avoid any differences due to 
oocyte production. The mtDNA copy number in the hermaphrodites fed by bacteria 
expressing polg-1 or mtss-1 dsRNA was approximately 80% and 70% respectively lower 
than the control adult hermaphrodites (Fig. 1B) but similar to that of L4 worms treated with 
very high concentration of EtBr (125 µg/ml), concentration already known to lead to mtDNA 
depletion [27]. 
As POLG1 mutations in human can result in either quantitative or qualitative mtDNA 
anomalies, we looked for mtDNA deletions in worms subjected to polg-1 knock-down. Long-
range PCR amplification of the nearly two-thirds of the genome in these worms revealed the 
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same mtDNA length product (9 kb) in polg-1 treated animals and controls ruling out that polg-
1 inactivation results in mtDNA deletion (Fig. 1C). 
 polg-1 silencing by RNAi was highly efficient and specific as polg-1 transcript was 
severely impaired in F1 progeny when subjected to RNAi feeding (Fig. 1D). We then 
analyzed the efficiency of mtss-1 RNAi in vivo. For this purpose, we constructed transgenic 
animals expressing a mtss-1::GFP fusion construct under the control of either the body-wall 
muscle specific myo-3 promoter (myo3-MTSS::GFP) or mtss-1 promoter and 3’-UTR 
regulatory sequences (par-MTSS::GFP). As shown in Figure 1E, the GFP signal appeared 
cytoplasmic and as punctuate foci. This signal is aligned and regularly spaced along 
myofibrilla within the cytoplasm of body-wall muscle cells in agreement with a mitochondrial 
localization. Feeding these transgenic worms with bacteria expressing mtss-1 dsRNA led to 
the loss of most of the MTSS::GFP punctuated signals (Fig. 1E), showing the efficiency of 
RNAi. Altogether, these results show that RNAi of polg-1 and mtss-1 over one generation 
lead to a specific knock-down of polg-1 and mtss-1, to a severe mtDNA depletion in somatic 
cells but does not result in major anomalies in worms development.  
 
Ethidium bromide exposure combined with polg-1 and mtss-1 knock-down results in 
an obvious developmental phenotype 
 To design a large scale screening of genes involved in mitochondrial genome 
maintenance using RNAi feeding, we need a clear and obvious phenotype, appearing rapidly 
during the worms life.  
 Ethidium bromide (EtBr) is a well-known nucleic acid intercalating compound that 
preferentially inhibits mtDNA replication and transcription. Exposure to EtBr results in a total 
loss of mtDNA in mammalian cells (ρ° cells ) [38-40] or diminished number of mtDNA copies 
in C. elegans [27] and Fig. 1B). Concentration and timing of the EtBr treatment during C. 
elegans development affects terminal developmental stages. Indeed, submitting L1 animals 
to high EtBr concentration (125 µg/ml) leads to a L3 stage arrest. Prolonged exposure to 
EtBr results in mtDNA depletion and L3 arrested larvae presented a 25-fold decrease of 
mtDNA content. Interestingly, the L3 arrest phenotype was reversible upon drug removal 
indicating that EtBr is not acting by causing mutations in either the mitochondrial or the 
nuclear genomes since these would be expected to be heritable and irreversible [27].  
 We reasoned that animals with low mtDNA content should be more sensitive to EtBr 
than animals with normal mtDNA content. Therefore silencing of genes controlling mtDNA 
copy number combined with EtBr exposure should rapidly reveal a defective phenotype. We 
therefore performed polg-1 and mtss-1 RNAi experiments on wild-type animals from the L1 
stage to the adult stage (3 days). The adults (F0) were then allowed to hatch 100 eggs (F1 
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progeny) on NGM plates seeded with bacteria expressing polg-1 or mtss-1 dsRNA, with and 
without increasing concentrations of EtBr (10 to 80 µg/ml). We then analyzed the 
development of the F1 larvae and evaluated the concentration at which 100 % of the larvae 
were arrested at the L3 stage. We observed that 100% of control larvae were arrested at the 
L3 stage after treatment with 80 µg/ml EtBr as previously reported [27] whereas as few as 20 
and 60 µg/ml EtBr were sufficient to stop development of worms fed with dsRNA for polg-1 
and mtss-1 respectively (Fig. 2A and 2B). Concentration of 50 µg/ml of EtBr appeared to 
clearly discriminate genes important for mtDNA stability (90 to 100% L3 arrest) compared to 
the control (50% L3 arrest). To confirm that this L3 arrest phenotype is indeed related to 
mtDNA maintenance, we further examined silencing of rrt-2 gene encoding the arginyl-tRNA 
synthetase predicted to be involved in mitochondrial translation and of pmp-4 gene encoding 
a peroxisomal protein homologous to human ABCD1, which when mutated leads to X-linked 
adrenoleukodystrophy [41]. The F1 progeny of worms submitted to RNAi of those genes 
shows 50-55% L3 arrest as control worms (Fig 2C). This clearly shows that the increased 
sensitivity towards EtBr exposure is specific to an effect on mtDNA replication. Altogether, 
these results show that combining RNAi of genes involved in mtDNA maintenance and EtBr 
exposure reveals a strong and specific phenotype that can be further used for large-scale 
screening in C. elegans. 
 
Identification of new C. elegans genes involved in mtDNA stability 
 In human, the nucleoid consists of 5-7 mtDNA copies associated with several 
proteins. The precise protein composition of nucleoid is still under debate and depends of the 
procedure used to isolate these proteins [42]. Recent studies identify a set of proteins 
associated with human mtDNA nucleoids [43, 44]. Among them, a set of 31 mtDNA cross-
linked proteins constitutes the core nucleoid proteins (class I) that are supposed to be closely 
related to mtDNA replication and transcription. A second class of proteins (class II) is part of 
nucleoids but not crosslinked to mtDNA. Finally, class III proteins are not found in native 
nucleoids [43]. Considering the efficiency of our screen on C. elegans, we decided to 
successively inactivate the genes coding proteins of the mitochondrial nucleoid with the aim 
to reveal genes involved in mtDNA maintenance. The human protein sequences were used 
to explore the C. elegans genome database (C. elegans Sequencing Consortium 1998) by 
BLAST searching. Several open reading frames were identified, some of them being already 
known as true orthologous genes. Among those genes, we could study those that did not 
lead to embryonic lethality in large-scale RNAi screens and were present in the Ahringer 
RNAi feeding library. As a first screen, we retained 19 C. elegans genes homologous to 16 
human mitochondrial nucleoid genes (Table 1). ANT2 and ANT3 were reported respectively 
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as class I and III nucleoid proteins [43]. As there is no direct orthology between any C. 
elegans ant gene and a particular human ANT gene, we decided to screen the five C. 
elegans mitochondrial ADP/ATP carrier proteins (ant-1.1, ant-1.2, ant-1.3, ant-1.4 and 
C47E12.2) as previously reported [45]. One of them ant-1.1 could not be included in our 
screen as its inactivation from L1 larval stage leads to sterility [45]. Moreover, due to the high 
sequence identities (84%) of ant-1.3 and ant-1.4 mRNA, RNAi of any of these two genes 
results in silencing of both ([45] and our results). Therefore results are presented for ant-1.4 
only. On the same way, IMMT human gene (Mitofilin) presents two orthologs in C. elegans, 
immt-1 and immt-2 that were both tested. 
 Using the Ahringer library feeding RNAi clones, we inactivated expression of those 
genes beginning from synchronized L1 larvae. After 3 days, adults were then allowed to lay 
around 100 eggs onto new RNAi plates with 50 µg/ml EtBr. At day 4 the percentages of L3 
arrested larvae versus gravid adults were counted (Fig. 3). This revealed a first group of 
genes for which inactivation resulted in 85 to 100% of L3 arrest. These genes are homologs 
of human genes encoding proteins of class I, mtss-1, polg-1, hmg-5, polrmt (Y105E8A.23), 
dnj-10, ANT (C47E12.2) and ant-1.4 but also of class II, atad-3, immt-1 and of class III, phi-
37. To confirm that inactivation of these genes led to mtDNA depletion, we quantified the 
relative mtDNA copy number of worms submitted to the same RNAi without any EtBr 
exposure. As shown on Fig. 3, all the animals treated by RNAi, which led to more than 85% 
EtBr sensitivity, presented obvious mtDNA depletion (10-40% of normal mtDNA content) 
except immt-1. None of these gene silencing resulted in a specific abnormal developmental 
phenotype (data not shown). To ascertain that the L3 arrest phenotype was due to specific 
inactivation of the targeted genes, we quantified by reverse transcriptase-PCR (RT-PCR) the 
expression of most of these genes during the RNAi experiments without EtBr exposure and 
consistently observed silencing of all genes (Fig. 4). These results therefore suggest that the 
proteins encoded by these genes are closely related to mtDNA replication.  
 A second group of genes was found for which inactivation did not result in any EtBr 
sensitivity (44 to 74% L3 arrest). Among them, mel-32, clpx (D2030.2), pyr-1, hsp-6 and 
ant1-2 encode proteins homologous of human proteins of the core nucleoid whereas dao-3, 
kat-1 and immt-2 are orthologs of the class II or III. Moreover, silencing of these genes does 
not result in major modification of the mtDNA copy number (Fig. 3). The same results were 
obtained with the inactivation of irk-1 and C34B7.2, two genes encoding proteins of unrelated 
mitochondrial function. irk-1 encodes a protein associated with the outer mitochondrial 
membrane homologous to human LRRK2 protein whom mutations result in Parkinson 
disease-8 and C34B7.2 encodes a putative cytosolic phosphoinositide phosphatase. Thus, 
whereas the human counterparts of the second group of genes are closely related to mtDNA, 
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at least in human, they seem not to be involved in mtDNA copy number control in C. elegans. 
 
Discussion 
  We have designed an efficient screening method for the identification of genes 
involved in the mitochondrial genome stability in C. elegans. Indeed, by combining RNAi of 
polg-1 and mtss-1 genes already known to be involved in mtDNA maintenance and EtBr 
exposure of worms, we were able to rapidly reveal a L3 developmental arrest associated with 
a severe decrease in mtDNA copy number. It has been shown that there is no mtDNA 
replication during the early larval stages and that transition from L3 to adulthood is 
associated with an important increase of mtDNA replication [27, 28]. Therefore we can 
hypothesize that EtBr exposure drastically inhibited replication of the low mtDNA content 
resulting from polg-1 or mtss-1 silencing. This developmental phenotype seems to be 
specific as silencing of other genes encoding either mitochondrial proteins not involved in 
mtDNA maintenance (C29H12.1, lrk-1) or non-mitochondrial proteins (pmp-4, C34B7.2) did 
not result in a L3 arrest and/or mtDNA depletion. Interestingly, with a notable exception 
(immt-1), only mtDNA quantitative anomalies were observed. This abnormal and specific 
phenotype is obvious after three days and therefore allows a very rapid screen that can be 
further used for large-scale screening in C. elegans. 
 We extended this screen to C. elegans genes encoding proteins homologous to 
human nucleoid proteins. The function of some of these proteins is clearly related to mtDNA 
stability. Indeed, the mitochondrial RNA polymerase, DNA polymerase, single strand DNA 
binding protein, Twinkle helicase or the transcription factor TFAM have been shown to 
directly interact with mtDNA in several species. We applied our screen to the C. elegans 
genes orthologous to human nucleoid encoding protein genes. This clearly showed us that 
inactivation of genes involved in mtDNA replication or transcription rapidly result in L3 
developmental arrest and mtDNA depletion confirming the efficiency of our screen. However, 
other proteins identified as true components of the human nucleoid (core nucleoid) do not 
display obvious function related to mtDNA maintenance. This is the case for SHMT2, CPS1 
or CLPX for example. SHMT2 (serine hydroxymethyltransferase) is primarily responsible for 
glycine synthesis, CPS1 (carbamoyl-phosphate synthetase 1) catalyzes the first committed 
step of the hepatic urea cycle and CLPX gene encodes a ClpX caseinolytic protease X 
homolog with no well-defined function. Whether these proteins are bifunctional proteins with 
a second function directly related to mtDNA maintenance or are structural components of the 
nucleoid with no direct function in mtDNA replication, transcription or translation is still under 
debate. Silencing of these genes by RNAi combined with EtBr exposure resulted in a normal 
mtDNA content, or an increased mtDNA content which can be the result of a general 
mitochondrial upregulation, and a L3 arrest level similar to that observed in control animals 
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suggesting no functional interaction with the mitochondrial genome. 
 Furthermore, our screen distinguishes five new genes involved in mtDNA 
maintenance in a pluricellular organism, atad-3, phi-37, dnj-10, immt-1 and Y105E8A.23.  
 ATAD3 is an AAA-domain protein, a class of proteins that is known to have important 
roles in DNA and RNA transactions. In human, ATAD3 was reported to be an intrinsic 
mitochondrial membrane protein embedded in the inner membrane leaving its AAA-domain 
directed towards the matrix [43, 46]. In C. elegans, atad-3, the homolog of vertebrate 
ATAD3, has been shown to be important for larval development and is required for proper 
organ function suggesting a crucial role of this protein for the up regulation of mitochondrial 
activity during the progression through larval stages [47]. Moreover, atad-3 (RNAi) animals 
showed drastic reduction of complex I and citrate synthase (CS) activities. The severe 
mtDNA depletion we observed after atad-3 silencing could explain this respiratory chain 
deficiency. Whether CS decrease is primary related to atad-3 suppression or secondary to 
mtDNA depletion has still to be demonstrated. It should be noted that CS is a class III protein 
of the nucleoid and that its decreased activity in atad-3 (RNAi) animals could therefore result 
from defective nucleoid assembly. Interestingly, in human and in flies it was shown that the 
ATAD3A protein does not bind mtDNA but rather participates in the connection between the 
inner and outer mitochondrial membranes regulating the mitochondrial dynamics [48]. 
Interactions between the mitochondrial inner and outer membranes control a number of 
central mitochondrial functions such as channeling of metabolites, protein transport, 
coordinated fusion and fission, and mitochondrial DNA inheritance. The relationship between 
mitochondrial network and mtDNA maintenance has been already demonstrated as 
mutations in OPA1, encoding a dynamin-related GTPase and being mainly involved in the 
mitochondrial network organization [49] results in multiple mtDNA deletions [7]. Our results 
strengthen the idea that ATAD3A, through interactions with proteins of the inner membrane, 
directly contributes to mtDNA maintenance within nucleoids. 
 phi-37 encodes the alpha subunit of mitochondrial ATP synthase and the human 
ATP5A protein is a class III nucleoid protein. It is hypothesized that class III proteins were 
adventitiously crosslinked to other nucleoid proteins [43]. Nevertheless, suppression of phi-
37 leads to highly sensitive worms to EtBr and mtDNA depletion. Whether this protein plays 
a direct role on mtDNA stability in addition to its role in the mitochondrial ATP synthase is 
very interesting and deserves more experiments. It can be also hypothesized that ATP 
synthase deficiency due to phi-37 silencing could induce cristae modifications and 
consequently avoid mtDNA attachment to the inner mitochondrial membrane resulting in a 
secondary mtDNA depletion [50-52].  
dnj-10 is homologous to human DNAJA3, also known as Tid1. A crucial role of 
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DNAJA3 for mitochondrial biogenesis has been demonstrated in mice where a progressive 
RC deficiency and decreased copy number of mtDNA were reported in cardiomyocytes 
lacking DNAJA3 [53]. Hsp70 and PolG have been identified as interactors of DnaJ3 
suggesting that DnaJ3, through its chaperone activity on PolG folding, thereby controls 
mtDNA replication. DNAJA3 function seems very well conserved through evolution since the 
invalidation of its homolog in yeast (Mdj1) that also interacts with the yeast mitochondrial 
DNA polymerase, causes mtDNA loss. Our results show that dnj-10 in C. elegans is also 
involved in mtDNA copy number control and could thus be a functional homolog of human 
DNAJA3. 
 Mitofilin (IMMT) is a protein anchored to the mitochondrial inner membrane, with a 
small N-terminal domain protruding in the mitochondrial matrix [54]. A role in protein import 
related to maintenance of mitochondrial structure was suggested as mitofilin helps to 
regulate mitochondrial morphology [55]. Recently, mitofilin has been implicated in the 
maintenance of the mtDNA integrity as depletion of mitofilin in human cultured cells causes 
accumulation of mtDNA damage [56]. In C. elegans two genes encode the IMMT homolog, 
immt-1 and immt-2. Inactivation of immt-1 only, the closest homolog of IMMT, leads to EtBr 
sensitivity but not to mtDNA depletion (Fig. 3).  
Y105E8A.23 encodes a protein highly homologous to the mitochondrial RNA 
polymerase (POLRMT). A direct relationship between RNA polymerase and mtDNA copy 
number has never been observed in animals. Only, the yeast mitochondrial RNA polymerase 
(RPO41) has been involved in the mitochondrial genome stability. The amino-terminal 
extension of the yeast mtRNA polymerase is required for a mtDNA maintenance function that 
is separable from the known RNA polymerization activity of the enzyme [57]. Our study adds 
new evidence of a role of the mitochondrial RNA polymerase on mtDNA stability in a 
pluricellular organism. 
 Finally, C. elegans genome contains five genes encoding ADP/ATP translocators. We 
found that only ant-1.2 (RNAi) worms resulted in a phenotype comparable to control animals. 
Interestingly, the ant-1.2 gene is the most divergent C. elegans ant gene. On the contrary, 
down expression of the C47E12.2 gene, more distantly related to ant genes, leads to EtBr 
sensitivity and mtDNA depletion. The function of ANT proteins is not confined to exchanging 
ADP/ATP between mitochondria and cytosol. Human ANT1 also contributes to programmed 
cell death [58] and mtDNA stability as a constituent of the nucleoid [3, 4]. Human ANT2 has 
been shown to also maintain ATP entry into mitochondria even when oxidative 
phosphorylation is impaired [59]. These results highlight the differential contribution of these 
C. elegans ANT proteins on mtDNA maintenance. 
 In conclusion, our work allowed to develop a rapid and efficient screening in C. 
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elegans for genes possibly involved in mtDNA maintenance. By applying this screen to 
genes homologous to human genes encoding proteins of the nucleoid, we identified new 
genes (Y105E8A.23, dnj-10, atad-3 and phi-37) that clearly show a direct control on mtDNA 
copy number. The human orthologs of these four genes (POLRMT, DNAJA3, ATAD3 and 
ATP5A1) should therefore be considered as candidate genes for patients with quantitative 
mtDNA anomalies. These results will now allow us to systematically invalidate all genes of 
the C. elegans genome with the aim to identify new components of the mitochondrial 
genome copy number control. It should be hypothesize that false positive will be obtained as 
it is the case for immt-1, the counterpart of fast high throughput screening being of course 
the risk of false positive or negative results. Obviously several of these genes would have 
been already identified as such but we hope to find new genes involved in mtDNA 
maintenance, to identify a yet unknown function of already described genes with no relation 
to any mitochondrial function or to identify transient nucleoid components in a temporal 
and/or spatial manner that could play important function on the stability and maintenance of 
mtDNA. This reservoir of new genes will represent a helpful tool and knowledge for 
mitochondrial diseases as they would be considered as candidate genes for patients. 
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Materials and Methods 
 
Strains and growth conditions 
The C. elegans wild type strain N2 Bristol and unc-119 (ed3)III were used in this work. The 
strains were maintained at 20°C on NGM plates seede d with OP50 E. coli strain. 
 
Generation of transgenic worms 
The entire mtss-1 gene with the promoter region or the mtss-1 coding sequence without stop 
codon were PCR amplified using mtss-1UP or mtss-1ATG as forward primers and mtss-1DW 
as reverse primer (Table 2). The amplification product of the mtss-1 coding sequence was 
cloned into the pPD136.61 vector in fusion with the GFP sequence. The resulting plasmid 
encoded MTSS1-1::GFP under the control of the myo-3 promoter. The entire mtss-1 gene 
containing the promoter sequence was fused in frame with the GFP coding sequence by 
using the PCR-fusion method [60] and cloned into the pGEMT-easy plasmid. Both plasmids 
and the plasmid pDPMM016b carrying an unc119(+) gene, were linearized and used to 
perform microparticle bombardments of the unc-119 (ed3) strain using the Bio-Rad Biolistic 
PDS-1000/HE (Bio-Rad laboratories) as described [61]. Following bombardment, worms 
were allowed to recover at 20°C and after 14 days, plates were examined for animals with 
wild type motility. Confirmation of the presence of the mtss-1::gfp transgenes was made by 
PCR. For each construct two independent transgenic worm lines were generated. 
 
RNA interference and EtBr assay 
The RNAi experiments were performed using the feeding procedure described by Kamath 
and Ahringer (2003) with slight modifications. Feeding RNAi clones were purchased from the 
Ahringer RNAi library (Geneservice Limited) and sequenced. A single colony of HT115 (DE3) 
bacteria of interest (RNase III-deficient E. coli strain, carrying IPTG-inducible T7-RNA 
polymerase) was first grown overnight at 37oC in LB-ampicillin. The bacteria were then 
seeded onto NGM plates with 1 mM IPTG, 25 µg/ml carbenicillin and 50 µg/ml ampicillin and 
incubated at room temperature in a dark container at room temperature for 48 h to allow the 
expression of the double-stranded RNA (dsRNA). Worms feeding on HT115 bacteria 
carrying the empty vector (L4440) were used as controls in all the experiments. 
Synchronized L1-stage N2 worms were placed onto NGM plates seeded with bacteria 
expressing the dsRNA of interest and were incubated for 72 h at 20oC. Four adult worms 
were independently picked up and transferred to fresh RNAi plates containing or not different 
concentrations of ethidium bromide (EtBr). Worms were allowed to lay 80 to 100 eggs before 
being removed. Eggs were immediately counted and the F1 progeny produced was analyzed 
after 3 and 4 days. At day 4, evaluation of the F1 progeny arrested at the L3 stage was 
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compared to the number of adults on the same plate. The phenotype was scored as 
sensitive to RNAi and EtBr if more than 80% of worms were arrested at the L3-stage on 
plates containing 50 µg/ml of EtBr. A gene was considered as positive for a given phenotype 
if the same result was observed in at least two independent feeding experiments.  
The specificity and efficiency of RNAi inactivation of each gene were checked by semi-
quantitative RT-PCR analyses. Total RNA was isolated from N2 animals fed on RNAi 
bacteria using Trizol reagent (Invitrogen). Total RNA were treated with DNaseI, then 
subjected to cDNA synthesis using the reverse transcriptase SuperScript VILOTM (Invitrogen) 
and PCR amplified. The primers used for each gene are listed in Table 2. The amplification 
of a 426 bp fragment of the ama-1 cDNA was used as internal control. 
 
Quantification of mtDNA and investigation of mtDNA integrity 
Extraction of total genomic and mitochondrial DNA was performed using the NucleoSpin 
Tissue extraction kit (Macherey-Nagel) from 10 F1-adult worms having laid all their eggs (day 
9) after RNAi treatment or from control adults at the same stage. The mitochondrial cytb and 
the nuclear K01H12.2 genes were individually amplified by real-time PCR using primers cytb-
f/cytb-r and K01H12.2-f and K01H12.2-r (Table 2) as previously reported [37]. The ratio of 
mtDNA copy number to nuclear DNA was used as a measure of mtDNA content in each 
specimen. Each Q-PCR measurement has been made in triplicate in at least two 
independent RNAi experiment. he integrity of mtDNA was checked by long-range PCR 
(Expand Long Template, Roche) using a pair of primers distant of 8561 bp (CE3 and CE4, 
Table 2).  
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Legends to Figures 
 
Figure 1. polg-1 (RNAi) and mtss-1 (RNAi) lead to mtDNA depletion. A, phenotype of polg-1 
(RNAi) and mtss-1 (RNAi) F1 adult worms. B, mtDNA copy number of control (L4440), polg-1 
(RNAi), mtss-1 (RNAi) and control adults treated from the L4 stage with 125 µg/ml EtBr 
(EtBr). The relative ratio of mtDNA copy number per adult is represented. C, Long-range 
PCR of the mtDNA extracted from polg-1 (RNAi) and L4440 control animals (C). M: 
molecular weight marker. D, polg-1 and ama-1 mRNA levels in N2 animals grown on bacteria 
expressing either polg-1 dsRNA or containing the empty L4440 RNAi vector (C) during larval 
development and adulthood. M: molecular weight. E, Expression of MTSS-1::GFP fusion 
protein in adult worms. MTSS-1::GFP was expressed either under its own promoter (par-
MTSS-1::GFP, (1) Normaski and (2) fluorescence) or under the body-wall muscle specific 
myo-3 promoter (myo-3-MTSS-1::GFP, (3). RNAi of mtss-1 gene in myo3-MTSS-1::GFP 
transgenic animals (5) compared to control RNAi (4).  
 
Figure 2. polg-1 (RNAi) and mtss-1 (RNAi) mutants are hypersensitive to the EtBr. A, L3 
larval development arrest after polg-1 (RNAi) and mtss-1 (RNAi) in the presence of 40 µg/ml 
of EtBr compared to control animals (L4440). B, Percentage of L3 larval arrest of polg-1 
(RNAi) (square), mtss-1 (RNAi) (triangle) and control animals (L4440) (circle) grown with 
increasing concentration of EtBr. Each point corresponds to the analysis of n> 80 animals in 
two independent experiments. C, Percentage of L3 arrest of worms submitted to RNAi of 
polg-1, mtss-1, rrt-2 and pmp-4 genes and 50 µg/ml EtBr exposure. L4440: control RNAi. 
 
Figure 3. Correlation between L3 arrest and mtDNA copy number. mtDNA content of adult 
worms after 9 days of RNAi of various genes (black bars). Values are presented as ratio of 
mtDNA versus nuclear DNA relative to the control (L4440 RNAi). The error bars represent 
the SD. Percentage of L3 arrested animals after RNAi and 50 µg/ml EtBr exposure (gray 
bars). Experiments were performed in at least two independent RNAi for each gene. 
 
Figure 4. Efficiency and specificity of RNAi. The expression level of various genes was 
estimated by semiquantitative RT-PCR after RNAi of the corresponding genes and in control 
(L4440). ama-1 transcript level was used as internal control. M: molecular weight 
 
Table 1. List of C. elegans genes homologous to human nucleoid genes. The three classes 
correspond to the nucleoid class of proteins described in Bogenhagen et al., 2008. Class I: 
proteins isolated in both native and crosslinked nucleoid preparations, class II: proteins 
observed in native nucleoids but not found crosslinked to mtDNA and class III: proteins 
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identified in crosslinked nucleoids but not found in native nucleoids. The two last columns 
show the Blast E-values between C. elegans and human genes.  
 
Table 2 
Oligonucleotides used in this study. 
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Nucleoid 
class
Human 
gene
C. elegans 
gene
C. elegans 
main gene
C. elegans description Blast E-
value
% length
I TFAM F45E4.9 hmg-5 HMG box-containing protein 4.0e-18 91.2%
I SSBP1 PAR2.1 mtss-1 Single-stranded DNA-binding protein 1.2e-09 65.9%
I POLG Y57A10A.15 polg-1 ortholog of human mitochondrial DNA polymerase gamma 7.6e-102 67.3%
I POLRMT Y105E8A.23 no description 1.2e-112 54.8%
I PEO1 F46G11.1 orthologous to the human mitochondrial DNA helicase twinkle 9.7e-56 80.3%
I CLPX D2030.2 Putative ATP-dependent Clp-type protease (AAA+ ATPase superfamily) 1.2e-103 91.8%
I DNAJA3 F22B7.5 dnj-10 protein containing a DnaJ ('J') domain that is predicted to be mitochondrial. 5.6e-83 83.8%
I ANT2/3 C47E12.2 Mitochondrial ADP/ATP carrier proteins 9.9e-77 94.4%
I ANT2/3 W02D3.6 ant-1.2 Mitochondrial ADP/ATP carrier proteins 8.49e-103 96.0%
I ANT2/3 T01B11.4 ant-1.4 Mitochondrial ADP/ATP carrier proteins 1.0e-106 92.0%
I SHMT2 C05D11.11 mel-32 Glycine/serine hydroxymethyltransferase 5.4e-156 91.9%
I HSPA1 C37H5.8 hsp-6 mitochondrial-specific chaperone that is a member of the DnaK/Hsp70 superfamily 1.5e-261 97.0%
I CPS1 D2085.1 pyr-1 orthologous to the human gene CPS1 carbamyl phosphate synthetase 0 65.9%
II ATADA3 F54B3.3 atad-3 AAA+-type ATPase 9.79e-173 96.3%
II IMMT T14G11.3 immt-1 Mitochondrial inner membrane protein (mitofilin) 1.8e-68 86.5%
II IMMT W06H3.1 immt-2 Mitochondrial inner membrane protein (mitofilin) 8.7e-32 86.9%
III MTHFD2 K07E3.3 dao-3 C1-tetrahydrofolate synthase 8.7e-78 95.4%
III ACAT1 T02G5.8 kat-1 homolog of the human gene ACAT1 Acetyl-CoA acetyltransferase 4.3e-115 94.6%
III ATP5A1 H28O16.1 phi-37 F0F1-type ATP synthase, alpha subunit 2.1e-225 93.5%
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Table 2
target genes primers PCR length
mtss1 mtss-1UP GAAGTTTTCTTGTGAAGAAGC
mtss-11ATG GGAAGATCTTAGAAAATGCTTCGTTCACTT
mtss-1DW CGGGATATCGGAAACAGTTATGTTTGG
RT-PCR ama-1-f (95-112) CAGTGGCTCATGTCGAGT
ama-1-r (559-577) CGACCTTCTTTCCATCAT 482 bp
ant1-2-f (46-65) CTCGCCTCCGGAGGCACTGC
ant1-2-r (606-627) GCCCGTCAGTTGAGTACAATG 581 bp
atad-3-f (291-311) GGCCAATATGAAATCAGAGCA
atad-3-r (626-647) CGGTTCTCTTCTTCGTGAAGC 356 bp
dnj-10-f (692-711) GTAATCGATGCAGAGGAAGT
dnj-10-r (1142-1162) CGCAGCCCAAGCCAACATAA 470 bp
C47E12.2-f (251-271) GGAGAGGAAACATGACAAATG
C47E12.2-r (717-737) GTGTCCCAAGGGTAGGTTAA 486 bp
immt-1-f (385-404) CCAAGAGAGCCCACACATGT
immt-1-r (814-834) GATCTCATCAAGCTGATGAG 449 bp
D2030.2-f (663-682) GCAGCAGCAGAGTAATAATC
D2030.2-r (1164-1184) CCAGAAGACGTACCAAATCC 521 bp
hmg-5-f (52-71) CGTGCTTCTGTCGCAGCTTC
hmg-5-r (563-583) CCCATTTCTGGAGGACGACA 531 bp
polg-1-f (19-39) ATGCAAATTTTCCACGTATCC
polg-1-r (619-638) CCCGACATCTGGCTCGATC 619 bp
phi-37-f (53-73) ATGCCGGAATCGCCACCACCG
phi-37-r (507-528) GATGGTGTCAATGGCAATGGC 475 bp
q-PCR cyb-f (158-177) CGCCCGATAGGTTAATAGCA
cyb-r (234-253) TGGCCCCATTAAAATGAAAA 95 bp
K01H12.2-f (502-522) CGTGAATTCAAAGGTCTGGCT
K01H12.2-r (602-622) AGTAAGCGGCACGGTAGATGA 120 bp
deletion CE3 (1840-1860) GAGCGTCATTTATTGGGAAG
CE4 (10529-10550) CACAAAGGTCGACATATCAAC 8710 bp
Table 2
